315 related articles for article (PubMed ID: 15990127)
1. Positive benefits of a pharmacist-managed hypertension clinic in Nigeria.
Erhun WO; Agbani EO; Bolaji EE
Public Health; 2005 Sep; 119(9):792-8. PubMed ID: 15990127
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.
Sookaneknun P; Richards RM; Sanguansermsri J; Teerasut C
Ann Pharmacother; 2004 Dec; 38(12):2023-8. PubMed ID: 15522983
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus related treatment goals: awareness and attainment in the Ife-Ijesa zone of south-western Nigeria.
Kolawole BA; Adegbenro C; Ayoola ZO; Opebiyi B
Afr J Med Med Sci; 2005 Dec; 34(4):389-94. PubMed ID: 16752671
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressure program.
McConnell KJ; Zadvorny EB; Hardy AM; Delate T; Rasmussen JR; Merenich JA;
Pharmacotherapy; 2006 Sep; 26(9):1333-41. PubMed ID: 16945056
[TBL] [Abstract][Full Text] [Related]
7. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
8. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
9. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
[TBL] [Abstract][Full Text] [Related]
10. Appraisal of the knowledge of hypertensive patients and assessment of the role of the pharmacists in the management of hypertension: results of a regional survey.
Ragot S; Sosner P; Bouche G; Guillemain J; Herpin D
J Hum Hypertens; 2005 Jul; 19(7):577-84. PubMed ID: 15830000
[TBL] [Abstract][Full Text] [Related]
11. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting.
Carter BL; Barnette DJ; Chrischilles E; Mazzotti GJ; Asali ZJ
Pharmacotherapy; 1997; 17(6):1274-85. PubMed ID: 9399611
[TBL] [Abstract][Full Text] [Related]
13. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
[TBL] [Abstract][Full Text] [Related]
14. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
Robinson JD; Segal R; Lopez LM; Doty RE
Ann Pharmacother; 2010 Jan; 44(1):88-96. PubMed ID: 20040704
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
[TBL] [Abstract][Full Text] [Related]
16. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
[TBL] [Abstract][Full Text] [Related]
17. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
18. The veterans' study to improve the control of hypertension (V-STITCH): design and methodology.
Bosworth HB; Olsen MK; Goldstein MK; Orr M; Dudley T; McCant F; Gentry P; Oddone EZ
Contemp Clin Trials; 2005 Apr; 26(2):155-68. PubMed ID: 15837438
[TBL] [Abstract][Full Text] [Related]
19. Pharmacist intervention program for control of hypertension.
Chabot I; Moisan J; Grégoire JP; Milot A
Ann Pharmacother; 2003 Sep; 37(9):1186-93. PubMed ID: 12921497
[TBL] [Abstract][Full Text] [Related]
20. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
Grant RW; Singer DE; Meigs JB
Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
